Could poison gas heal lungs? small trial tests carbon monoxide for ARDS

NCT ID NCT03799874

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This phase II trial tested whether inhaling low doses of carbon monoxide (200 ppm for 90 minutes daily for 3 days) is safe and helpful for people with acute respiratory distress syndrome (ARDS), a severe lung condition. Only 4 intubated adults participated, making this a very small study. The main goal was to check for side effects and measure changes in a blood marker of cell damage.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
inhaled carbon monoxide
What this could lead to
If it works, this could point toward a new treatment for ARDS, a severe lung condition with few options.
What could go wrong
This is a very small, early-phase trial with only 4 participants, so results are not reliable. Carbon monoxide is toxic at high levels, and safety is a major concern.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Brigham and Women's Hospital

    Boston, Massachusetts, 02115, United States

  • Duke Regional Hospital

    Durham, North Carolina, 27704, United States

  • Duke University Hospital

    Durham, North Carolina, 27710, United States

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • New York-Presbyterian Brooklyn Methodist Hospital

    Brooklyn, New York, 11215, United States

  • Washington University

    St Louis, Missouri, 63130, United States

  • Weill Cornell Medical College

    New York, New York, 10065, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.